Doz

Poractant alfa (surfactant)

پوراکتانت آلفا (سورفکتانت)

⚠ Unverified

🌬️ Respiratory SystemPulmonary surfactant

👶 Children:Use with caution 🇮🇷 Registered in Iran 🇺🇸 FDA approved (BLA) BLA020744ATC R07AA02

Market / country: 🇺🇸 USA

Curosurf (US)

🧮 Dose calculator

Neonatal respiratory distress syndrome · Regimen source: FDA Curosurf · 2.2

Enter age and weight.

🛡️ Safety & information

Formulations

  • 80 mg/mL (120 mg/1.5 mL; 240 mg/3 mL) intratracheal suspension — suspension 🇺🇸 USA FDA Curosurf · 3

👥 Special populations

  • 🤰 PregnancyNo data

    The source for this drug has no section for this group.

  • 🤱 BreastfeedingNo data

    The source for this drug has no section for this group.

  • 👶 ChildrenUse with caution

    The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Curosurf · 8.4

    “The safety and effectiveness of CUROSURF for the rescue treatment, including the reduction of mortality and pneumothoraces, of Respiratory Distress Syndrome (RDS) have been established in premature infants and the information on this use is discussed throughout the labeling.”
  • 👴 Older adultsNo data

    The source for this drug has no section for this group.

  • ⚥ Females & males of reproductive potentialNo data

    The source for this drug has no section for this group.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Inspired by the Saphira project; part of the content is taken from it.

Contact and correction requests — Telegram: @cenaav